Volpara Solutions Launches Two Quantitative Breast Imaging Tools to Work with its Globally Used, Multi-Vendor VolparaDensity Volumetric Breast Density Software
Vienna, Austria (PRWEB) March 07, 2014
Volpara Solutions today announced the launch of VolparaAnalytics and VolparaDose, two new quantitative breast imaging software tools built on the Volpara algorithm which enables the generation of volumetric measurements, including density, patient specific dose, and applied pressure. The Company is showcasing the expanded suite of breast imaging software tools for the first time, here at the European Congress of Radiology (ECR) meeting, March 6-10, 2014. (ECR2014 – First level gallery, booth 619).
Cleared by the FDA, HealthCanada, the TGA and CE-marked, VolparaDensity is used globally by radiologists to objectively assess density from both digital mammography and tomosynthesis images and help evaluate who might benefit from additional screening. Highly correlated to breast MR assessments, VolparaDensity is a reliable tool which automatically generates an objective, automatic measurement of volumetric breast density and a FDA cleared BI-RADS breast density category. To date, more than 2 million women have had their volumetric breast density analyzed using VolparaDensity.
“My nurses and colleagues find VolparaDensity easy to use with minimal training. We use it to objectively determine high density before performing breast ultrasound screening. In tandem, my colleagues in gynecology are finding it interesting to use the volumetric measurements to follow hormonal and anti-hormonal therapy,” said Professor André Grivegnée, Jules Bordet Institute, Brussels, Belgium.
VolparaAnalytics assists in quality assurance by monitoring and recording critical elements of the breast imaging process, including mammography, tomosynthesis and technologist performance. The software generates key imaging performance metrics to help understand the performance of technologists, readers and mammography machines and presents the information inside an easy-to-use dashboard.
For each image received, VolparaAnalytics automatically extracts information about the x-ray physics parameters used, records mammography and technologist identifiers, and computes various novel metrics from that data, including volumetric breast density and pressure. Real-time alerts and reports can demonstrate, for example, whether one technologist is compressing too much, or if one mammography unit is operating differently to the others. This comparative information can help determine whether additional training or re-calibration is required.
A study recently published in the British Journal of Radiology established that there is a wide variation in compression force and breast thicknesses for the same patient when they are imaged by different technologists. Clinical implications of this range from variations in dose exposure to potential variations in image quality and lesion visibility. In another recent study recently published in Radiology, researchers questioned the utility of a universal recall rate goal and suggest that targets have to be adjusted on the basis of local population factors.
“With VolparaAnalytics, breast screening programs can now evaluate individual and regional differences in screening performance in the context of volumetric breast density. In research being presented this week at ECR, researchers from the DENSE trial will showcase results that suggest a geographical variation in mammographic density distribution is present in the Netherlands, which would support structural assessment of breast density within the screening programme,” said Ralph Highnam, CEO of Volpara Solutions.
VolparaDose moves away from manufacturer-specific radiation dose estimates to using a standard mean glandular dose algorithm along with the patient-specific volumetric breast density to give a better estimate of the dose absorbed by the specific breast. The dose can be inserted directly into patient letters on compatible mammography reporting systems, and sent to enterprise wide dose tracking systems. Currently, mammography systems generate a Mean Glandular Dose (MGD) based on an assumption of a homogeneous mixture of fat and fibroglandular tissue in standard proportions.
“We all know it’s critical to keep radiation dose as low as possible whilst retaining high image quality, and yet the current dose estimates in mammography may significantly under or over-estimate the actual patient dose because they generate calculations based on assumption of a homogeneous mixture of fat and fibroglandular tissue in standard, non-personalized proportions. We are presenting research this week which demonstrates that it is possible to improve the personalization of radiation dose estimation, which may, in turn, allow for better optimization of radiation dose in breast screening, both in mammography and tomosynthesis,” added Dr. Highnam.
About Volpara Solutions
Founded to enable radiologists to give women the most accurate information possible regarding their breast health, Volpara Solutions is the wholly owned sales and marketing arm of Matakina Technology Limited of New Zealand. Matakina’s founders and Board of Directors includes John Hood, PhD, former Vice Chancellor of the University of Oxford, UK; Ralph Highnam, PhD, former CEO of Mirada Solutions, one of the University of Oxford’s most successful spin-outs of recent times and co-author of the seminal book Mammographic Image Analysis; and Professor Sir Michael Brady, a serial entrepreneur who recently retired from the University of Oxford where he was Professor of Information Technology for 25 years.
Special Bonus Gift â€“ the “Goddess” Denim Apron â€“ a .99 value! Show off your Goddess status in the kitchen with this fun blue denim Goddess Apron, decorated with silver glitter and rhinestones. This adorable apron is made of thick, machine-washable cotton, and comes with convenient deep double pockets and adjustable neck strap and waist tie. The Natural Hormone Solution to Enjoy Perimenopause Why are so many young women in their thirties and forties feeling like PMS is their new normal? On a roller-coaster ride of emotions, they are uncharacteristically cranky and fatiguedâ€”a bitchy, nasty, fuzzy-minded person they barely recognize and donâ€™t enjoy (and neither, by the way, do their partners and families). Itâ€™s perimenopause, that lesser-known term defining the years when womenâ€™s hormones are kissing them good-bye, before they reach menopause. Perimenopause takes a big toll on womenâ€™s moods, health, and relationships. Suzanne informs women as young as 35 what to do when they start to experience hormonal shifts that wreak havoc on their lives, prime them for cancer and other chronic and deadly health issues, and make them feel plain miserable. She discusses: The minor hormones (or why youâ€™re feeling so crappy) The major hormones and the importance of maintaining balance among them How hormones serve as protection against many of the diseases of aging BHRTâ€”bioidentical hormone replacement therapyâ€”and what the research really says about synthetics vs. bioidenticals The safety of bioidentical hormonesâ€”why few women would turn down an antibiotic to save their life, but they might decline a hormone that could prevent a deadly heart attack Informative study results like these: In 1996, the American Cancer Society published a study of 422,373 postmenopausal women who were cancer free at the beginning of the nine-year study. They found that women of all ages who took estrogens experienced a 16 percent decreased risk of dying from breast cancer, compared to nonusers, and that women who experienced natural menopause by the age of 40 and who used bioidentical hormone replacement therapy (BHRT) had a 41 percent decreased chance of dying from breast cancer. The foods and nutrients that energize, plus exercise and other lifestyle shifts to consider Hidden factors that could be sustaining your symptoms; for example, as many as 60 percent of people suffer from undetected food allergies with symptoms like headaches, fatigue, inability to focus, joint pain, anxiety, and depression The Symptom Solverâ€”specific nutritional and other interventions to address the most common symptoms like hot flashes, painfully swollen breasts, breakthrough bleeding, weight gain, yeast infection and candida, and more Real questions and real answers about perimenopause from top physicians Bonus materials, including letters from women who have been there and have been helped with BHRT, plus much more With a foreword by Dr. Prudence Hall, renowned gynecologist, on the patients and studies that support bringing hormones back to a youthful healthy balance, as soon as they begin to decline Once again, Suzanne Somers is telling it like it is, to benefit women and help them improve their health, lifestyles, and relationships. Iâ€™M TOO YOUNG FOR THIS! is empowering, liberating, practical, informative, and will help women add joy to their years, and quite possibly, add years to their lives. [break] Hardcover: 288 pages Publisher: Harmony; 1 edition (September 24, 2013) Language: English ISBN-10: 0385347693 ISBN-13: 978-0385347693 Product Dimensions: 9.3 x 6 x 1.1 inches
List Price: 22.99
This book includes daily messages which are my little inspirations! The wisdom which has helped me on my path to a life that I enjoy to the fullest each and everyday. Read a day at a time, or all in one sitting. This book is a daily reminder to keep our problems in perspective, not to sweat the small stuff, and to be grateful for the simple joys of life. Hardcover: 336 pages Publisher: Crown; 1 edition (November 30, 1999) Language: English Editorial Reviews Amazon.com Review TV personality Suzanne Somers offers a book of 365 daily affirmations, designed to create a “shift in thinking.” “Holding onto old hurts and programmed ideals creates blockages that prevent change and growth,” she writes. “Do you really desire happiness, peace of mind, and serenity? You can have it…. But you have to surrender the old hurts and self-serving thinking.” By reading her day-by-day essays, readers will find support in being more honest with oneself, healing relationships, creating tranquility, committing to soul dreams, and listening to intuition. So often people put off bliss and peace, assuming they are gifts for the future, notes Somers. But why wait for our birthrights, when the present is here, right now, just waiting to be appreciated? Somers’s heart is in the right place, and although she is more accurately described as a caring celebrity than a disciplined spiritual guru, her legion of fans will find this a tender and meaningful companion to guide them through years ahead.
List Price: 14.99
Phoenix, AZ (PRWEB) March 06, 2014
On Saturday, March 8, 2014, the National Alliance for Hispanic Health kicks off the 2014 ¡Vive tu vida! Get Up! Get Moving!® 10-event series in Phoenix, Arizona with local community-based organization partner, Concilio Latino de Salud.
The event will feature bilingual health insurance navigators to answer questions and offer attendees assistance with enrollment for new health insurance options for adults and children under the Arizona Health Insurance Marketplace and Medicaid. The event this weekend is free and open to the public and will be held at the John R. Davis Elementary School at 6209 S. 15th Avenue in Phoenix, from 8:00 am to 2:00 pm.
“¡Vive tu vida! Get Up! Get Moving!® is a great opportunity to learn fun, safe, affordable, and effective ways for the whole family to be physically active,” said Elizabeth Ortíz de Valdez, President and CEO of Concilio Latino de Salud.
Made possible by an extraordinary group of partners and volunteers, the Phoenix event will also feature free health information and screenings, including blood pressure, blood glucose, mammograms, and dental exams for kids; a Zumbathon, jump rope exercises, and youth soccer clinics. Participants will also have the chance to win prizes, enjoy healthy snacks, listen to music, watch folkloric dances, and much more.
About the National Alliance for Hispanic Health (The Alliance)
The Alliance is the nation’s foremost science-based source of information and trusted advocate for the health of Hispanics in the United States. The Alliance represents thousands of Hispanic health providers across the nation providing services to more than 15 million each year, making a daily difference in the lives of Hispanic communities and families. For more information, visit http://www.hispanichealth.org or call the Alliance’s Su Familia National Hispanic Family Health Helpline at 1-866-783-2645.
Related Mammogram Press Releases
Molecular Subtyping of Breast Cancer Can Better Identify Women at High Risk of …
The USF study examined why different genomic tests for breast cancer sometimes provide contradictory information about risk of recurrence. The key findings involved the 70-gene MammaPrint® test; the 21-gene Oncotype DX® test, which is an earlier …
Read more on Business Wire (press release)
Breast cancer champion looks ahead
Ms Boyle said the free events Leg 2 aimed to arm breast cancer sufferers with information. She said it was also a great opportunity for women with breast cancer to connect with other women who had experienced similar journeys. Ms Boyle said when she …
Read more on The North West Star
Breast Cancer Charity CoppaFeel! (And Critics) Speak Out About Controversial …
Breast cancer, in its simplest definition, is cancer that starts in the cells of the breast. But what we call <a href="http://www.cancer.ca/en/cancer-information/cancer-type/breast/overview/?region=on" target="_hplink">"breast cancer"</a> actually …
Read more on Huffington Post UK
Some recent mammography auctions on eBay:
Mammography Exam Review by Erica Koch Wight and Jennifer R. Wagner (2007,...
|$49.99 (0 Bids)|
End Date: Saturday Mar-15-2014 7:52:08 PDT
Buy It Now for only: $99.99
Buy It Now | Bid now | Add to watch list
Mammography and Breast Imaging PREP: Program Review and Exam Prep, Peart, Olive,
End Date: Sunday Apr-6-2014 0:59:49 PDT
Buy It Now for only: $41.54
Buy It Now | Add to watch list
Indianapolis, IN (PRWEB) March 06, 2014
The Diagnostics Marketing Association (DxMA) announced today its 2013 Marketer of the Year: Genomic Health. This award recognizes diagnostic industry innovation by marketers in highlighting their company and/or products and will be presented during the annual DxMA Global Marketing Summit to be held in San Francisco, CA on April 16-17, 2014.
Genomic Health is a leading provider of genomic-based diagnostic tests that help improve the quality of cancer treatment decisions. Genomic Health was selected for the Marketer of the Year Award for their “Pass It On, Until Every Woman Knows” campaign, a viral, online educational campaign developed to create a new movement of awareness around a simple message―not every woman with early stage breast cancer needs chemotherapy. Their test, Oncotype DX®, helps newly diagnosed breast cancer patients and their physicians determine if she needs chemotherapy.
“Over the past decade, Genomic Health has redefined personalized medicine through the innovation of Oncotype DX, making genomics an indispensable part of breast cancer diagnosis and treatment,” said Kimberly J. Popovits, Chairman of the Board, Chief Executive Officer and President of Genomic Health. “It is our goal to reach everyone with messages about personalizing early-stage breast cancer treatment so that when a woman is diagnosed with breast cancer she will already know, or be told, about Oncotype DX. We remain steadfast in our mission to pass it on, until every woman knows!”
The “Pass It On, Until Every Woman Knows” campaign includes a consumer-based website, Facebook, YouTube and Twitter social media platforms to build awareness of the Oncotype DX test, and . has reached over 100 million people so far with an active Facebook community of more than 175,000 strong. Genomic Health continues to engage the breast cancer community with this campaign through the use of infographs and interactive campaigns.
For more information on attending the DxMA’s Global Marketing Summit and learning more about Genomic Health and their “Pass It On, Until Every Woman Knows” campaign, please click here.
About DxMA (Diagnostics Marketing Association)
The DxMA builds diagnostic industry leadership by providing knowledge and opportunities for professional development and the exchange of ideas. We serve marketing, regulatory compliance, business development and medical affairs professionals who have devoted their careers to the diagnostics, device and life science market segments. Members benefit from continued education and insight, networking with marketers from leading diagnostic companies and service providers, and the AACC seminar and DxMA Global Marketing Summit. For more information on the DxMA, visit the DxMA’s website.
About Genomic Health
Genomic Health, Inc. (NASDAQ: GHDX) is the world’s leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient’s journey, from screening and surveillance, through diagnosis, treatment selection and monitoring. Genomic Health’s lead product, the Oncotype DX® breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS). In addition to this widely adopted test, Genomic Health provides the Oncotype DX colon cancer test, the first multi-gene expression test developed for the assessment of risk of recurrence in patients with stage II and stage III disease, and the Oncotype DX prostate cancer test, which predicts disease aggressiveness in men with low risk disease. As of September 30, 2013, more than 19,000 physicians in over 70 countries had ordered nearly 400,000 Oncotype DX tests. The company is based in Redwood City, California with European headquarters in Geneva, Switzerland. For more information, please visit, Genomic Health’s website and follow the company on Twitter: @GenomicHealth.
Breast cancer is the most common cancer among women, with roughly 175,000 new cases reported each year. Conventional treatment for breast cancer generally consists of chemotherapy, radiation and surgery, depending upon the extent of the disease. Some women are now opting for a more natural treatment regimen, either in conjunction with the chemotherapy and radiation, or with herbs alone. Some of the following herbs are currently being used for women with breast cancer, with promising results.
Astragalus root, Maitake mushrooms, echinacea and ginseng are used to boost the immune system, which is clearly not functioning properly in an individual with cancer.
Black cohosh, red clover, chasteberry and turmeric are herbs that are high in phytoestrogens. Phytoestrogens are a form of estrogen that block the stronger, more damaging estrogens. They work by fitting into the same receptors in breast cells that estrogens do, thus preventing the estrogen’s ability to fit there. Chasteberry also may inhibit the growth of breast cancer cells.
Silymarin, an extract of milk thistle, and also a powerful antioxidant, has shown promise for fighting breast cancer. Silymarin also provides an added benefit of protecting the liver.
Some cancer-fighting nutrients that can be added to the diet include green tea, garlic and onions. Studies have shown that the organic ingredient of garlic, allyl sulfur, is effective in inhibiting or preventing cancer development. Green tea acts as a powerful antioxidant and stimulates the immune system. It can be either drank in tea form, or taken in a standardized capsule.
Herbs such as bloodroot, don quai, juniper and mandrake may help reduce breast cancer cell growth.
Burdock root acts as a powerful antioxidant.
It helps to protect against cancer by helping control cell mutation. It also aids in elimination of toxins. Burdock purifies the blood and stimulates the digestive and immune systems.
In addition to herbs that are taken orally, homemade cancer creams may be placed on the affected breast or breasts. These creams contain extracts of herbs and work by promoting a separation of the tumor from the tissue that supports it. Cancer creams are applied to skin tumors or the skin over internal tumor sites. The ingredients differ, but usually are mixed in an oily base like beeswax, olive oil, butter or pine tar, which allow the active ingredients to penetrate the skin. Ingredients may include bloodroot, cleavers herb, lobelia, chickweed, cayenne, DMSO, chaparral, Irish moss, comfrey, marshmallow, myrrh, birch bark and mullein.
As with any health care regimen, consult your doctor or naturopath to determine the correct herbs and dosages for you.
Receive a free consultation from a dietitian with the American Dietitans for Health
Find More Breast Cancer Treatment Articles